MedTrace Logo

Lenalidomide Adherence in Older Adults

NCT03779555 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2020-10-22

No results posted yet for this study

Summary

To describe patterns of adherence and pilot baseline measures to investigate factors associated with lower adherence to lenalidomide in older adults with myeloma.

Conditions

Interventions

OTHER

Medication Event Monitoring System

-Microchipped bottle cap

Sponsors & Collaborators

  • Alliance for Clinical Trials in Oncology

    collaborator OTHER

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Mark A Fiala, MSW · Washington University School of Medicine

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-13
Primary Completion
2020-08-31
Completion
2020-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03779555 on ClinicalTrials.gov